1402
G. Ma´jer et al. / Carbohydrate Research 342 (2007) 1393–1404
were separated by column chromatography using
EtOAc–n-hexane (8:2). Compound 17a was isolated as
a syrup (70 mg, 22%): [a]D +38.3 (c 0.3, CHCl3), lit.24
+35.8; Rf = 0.250 (n-hexane–EtOAc, 8:2); 1H NMR
(500 MHz, CDCl3): d 7.33–7.19 (m, 20H, Ph), 4.98 (d,
1H, J = 11.1 Hz, CH2Ph), 4.91 (d, 1H, J = 11.6 Hz,
CH2Ph), 4.89 (d, 1H, J = 11.6 Hz, CH2Ph), 4.85 (d,
1H, J = 10.6 Hz, CH2Ph), 4.83 (d, 1H, J = 11.00 Hz,
CH2Ph), 4.62 (d, 1H, J = 5.3 Hz, CH2Ph), 4.59 (d, 1H,
J = 4.0 Hz, CH2Ph), 4.52 (d, 1H, J = 12.1 Hz, CH2Ph),
4.12 (t, 1H, J = 8.9 Hz), 4.04–4.00 (m, 3H), 3.75 (dd,
1H, J = 11.2, 3.7 Hz, H-8a), 3.70–3.67 (m, 3H), 3.29
(s, 3H, OCH3), 2.82 (d, 1H, J = 14.0 Hz, H-2a), 2.78
(d, 1H, J = 14.0 Hz, H-2b), 1.17 (t, 3H, J = 7.13 Hz,
COOCH2CH3); 13C NMR (125 MHz, CDCl3): d 169.0
(COO), 138.6, 138.4, 138.3, 138.1 (4C-quat. Ph),
128.3–127.4 (20C, Ph), 100.1 (C-3), 83.3, 80.8, 78.3 (C-
4, C-5, C-6), 75.5, 75.4, 75.0, 73.3 (4CH2Ph), 72.6 (C-
7), 68.6 (C-8), 60.5 (COOCH2CH3), 47.9 (OCH3), 36.9
(C-2), 14.0 (COOCH2CH3). Anal. Calcd for C39H44O8:
C, 73.10; H, 6.90. Found: C, 72.98; H, 6.89. Compound
17b (100 mg, 31%): [a]D +41.7 (c 0.2, CHCl3), lit.24
ꢁ28.5; Rf = 0.30 (n-hexane–EtOAc, 8:2); 1H NMR
(500 MHz, CDCl3): d 7.19–7.32 (m, 20H, Ph), 4.86 (d,
1H, J = 11.2 Hz, CH2Ph), 4.84 (d, 1H, J = 1.5 Hz,
CH2Ph), 4.81 (d, 1H, J = 1.8 Hz, CH2Ph), 4.77 (d, 1H,
J = 11.2 Hz, CH2Ph), 4.64–4.60 (m, 3H, CH2Ph), 4.52
(d, 1H, J = 12.1 Hz, CH2Ph), 4.13–4.03 (m, 2H,
COOCH2CH3), 3.89 (dd, 1H, J = 10.2, 8.8 Hz), 3.83–
3.78 (m, 3H), 3.73 (dd, 1H, J = 8.4, 7.4 Hz, 8-Ha), 3.70
(dd, 1H, J = 10.8, 1.7 Hz, H-8b), 3.43 (s, 3H, OCH3),
2.96 (d, 1H, J = 14.0 Hz, H-2a), 2.81 (d, 1H,
J = 14.0 Hz, H-2b), 1.20 (t, 3H, J = 7.16 Hz,
COOCH2CH3); 13C NMR (125 MHz, CDCl3): d 169.0
(COOEt), 138.4, 138.3, 138.1, 138.1 (4C-quat. Ph),
128.3–127.4 (20C, Ph), 101.6 (C-3), 83.4, 79.6, 77.5 (C-
4, C-5, C-6), 74.9, 74.7, 73.5 (3CH2Ph), 73.4 (C-7), 73.3
(CH2Ph) 68.8 (C-8), 60.4 (COOCH2CH3), 48.9 (OCH3),
37.0 (C-2), 14.1 (COOCH2CH3). Anal. Calcd for
C39H44O9: C, 73.10; H, 6.92. Found: C, 73.19; H, 6.83.
CHCl3); lit.31 +24.7; Rf = 0.55 (CH2Cl2–acetone 95:5);
1
The H and 13C NMR data were consistent with those
reported previously.31,38 Anal. Calcd for C35H38O6: C,
75.79; H, 6.91. Found: C, 75.69; H, 6.93.
3.17. Ethyl 3,4,5,7-tetra-O-benzyl-1,2-dideoxy-2-thio-a-
D-gluco-hept-2-ulopyranoside (19)
Compound 18 (555 mg, 1.00 mmol) was converted by
method C at 0 ꢁC for 3.5 h to give 19, and purified by col-
umn chromatography using CH2Cl2–acetone (98:2).
Compound 19 (180 mg, 30%): [a]D +65.0 (c 0.2, CHCl3);
Rf = 0.80 (CH2Cl2–acetone, 120:2); 1H NMR (200 MHz,
CD3Cl3): d 7.37–7.14 (m, 20H, Ph), 4.91 (d, 1H,
J = 11.6 Hz, CH2Ph), 4.85 (s, 2H, CH2Ph), 4.83 (d, 1H,
J = 11.6 Hz, CH2Ph), 4.74 (d, 1H, J = 11.6 Hz, CH2Ph),
4.64 (d, 1H, J = 11.6 Hz, CH2Ph), 4.61 (d, 1H,
J = 11.6 Hz, CH2Ph), 4.54 (d, 1H, J = 11.4 Hz, CH2Ph),
4.47 (d, 1H, J = 11.6 Hz, CH2Ph), 4.12–4.06 (m, 2H),
3.73 (dd, 1H, J = 4.4, 11.1 Hz) 3.76–3.59 (m, 2H), 3.41
(d, 1H, J = 9.2 Hz, H-3), 2.58–2.40 (m, 2H, SCH2CH3),
1.61 (s, 3H, CH3-1), 1.23 (t, 3H, J = 7.5 Hz, SCH2CH3);
13C NMR (50 MHz, CD3Cl3): d 138.8, 138.2 (3·) (4C-
quat. Ph), 128.8–127.5 (20C, Ph), 89.1 (C-2), 85.8, 83.9,
78.5 (C-3, C-4, C-5), 75.6, 75.6, 74.9, 73.3 (4CH2Ph),
72.9 (C-6), 68.9 (C-7), 27.5 (C-1), 19.8 (SCH2CH3),
14.4 (SCH2CH3). Anal. Calcd for C37H42O5S: C, 74.22;
H, 7.07. Found: C, 74.15; H, 7.14.
3.18. Methyl 3,4,5,7-tetra-O-benzyl-1-deoxy-a-D-gluco-
hept-2-ulopyranoside (20a) and methyl 3,4,5,7-tetra-O-
benzyl-1-deoxy-b-D-gluco-hept-2-ulopyranoside (20b)
Compound 19 (317 mg, 0.53 mmol) was converted by
method A to give a mixture of 20a and 20b. The ano-
mers were separated by column chromatography using
CH2Cl2–acetone (60:1). Compound 20a was isolated as
a syrup (55 mg, 18%): [a]D +20.3 (c 0.4, CHCl3), lit.31
+21.3; Rf = 0.59 (n-hexane–EtOAc 7:3); 1H NMR: d
7.41–7.10 (20H, Ph) 4.93 (d, 1H, J = 11.0 Hz, CH2Ph),
4.91 (d, 1H, J = 11.3 Hz, CH2Ph), 4.87 (d, 1H,
J = 11.1 Hz, CH2Ph), 4.83 (d, 1H, J = 10.8 Hz, CH2Ph),
4.68 (d, 1H, J = 12.3 Hz, CH2Ph), 4.63 (d, 1H,
J = 13.2 Hz, CH2Ph), 4.52 (d, 1H, J = 10.82 Hz,
CH2Ph), 4.54 (s, 1H, CH2Ph), 4.13–4.03 (m, 1H),
3.74–3.62 (m, 4H), 3.35 (d, 2H, J = 9.6 Hz, H-3), 3.22
(s, 3H, OCH3), 1.27 (s, 3H, CH3-1); 13C NMR
(125 MHz, CDCl3): d 138.7, 138.2, 138.2, 138.0 (4C-
quat. Ph), 128.7–127.5 (20C, Ph), 100.3 (C-2), 83.8,
83.3, 78.6 (C-3, C-4, C-5), 75.6, 75.5, 74.9, 73.3
(4CH2Ph), 71.5 (C-6 or C-7), 68.8 (C-6 or C-7), 47.9
(OCH3), 19.9 (C-1). Anal. Calcd for C36H40O6: C,
76.03; H, 7.09. Found: C, 76.11; H, 7.01. Compound
20b (75 mg, 25%): [a]D +9.5 (c 0.1, CHCl3); Rf = 0.69
3.16. 3,4,5,7-Tetra-O-benzyl-1-deoxy-a-D-gluco-hept-2-
ulopyranose (18)
To a stirred solution of compound 14 (2.70 g, 5.0 mmol)
in dry Et2O (30 mL) was added freshly prepared
CH3MgI in dry Et2O (25 mL, CH3MgI content
ꢀ1.10 g, 6.50 mmol) at ꢁ10 ꢁC. The mixture was kept
at ꢁ10 ꢁC until the TLC showed complete conversion
(15 min). The reaction was quenched by addition of
5% aqueous NH4Cl, the mixture was diluted with
CH2Cl2, extracted three times with water, dried and
evaporated. The residue was purified by column chro-
matography using CH2Cl2–acetone (95:5) to give 18 as
white crystals (1.26 g, 84%): mp 83–84 ꢁC (ethyl-ace-
tate–n-hexane), lit.31 92–93 ꢁC; [a]D +23.9 (c 0.3,
1
(n-hexane-EtOAc, 7:3); H NMR (500 MHz, CDCl3): d
7.35–7.14 (m, 20H, Ph), 4.91 (d, 1H, J = 11.3 Hz,